Navigation Links
New Analysis Finds Bioidentical Hormones Safer Than Standard Hormone Replacement Therapy
Date:2/23/2009

Comprehensive review demonstrates bioidentical hormones are superior to synthetic HRT with greater cardiovascular benefits and reduced risk of breast cancer

TORRANCE, Calif., Feb. 23 /PRNewswire/ -- The most comprehensive analysis to date, published in the Postgraduate Medical Journal, a leading peer-reviewed publication for practicing clinicians, showed that bioidentical hormones are associated with reduced health risks and are more efficacious than their synthetic counterparts. Conducted by a leading expert in hormone replacement, Kent Holtorf, M.D., medical director of the Holtorf Medical Group in Torrance, California, the paper reviewed and evaluated results from more than 200 physiological and clinical studies. It demonstrated that bioidentical hormone replacement therapy is both more effective and has greater health benefits for women suffering with symptoms of menopause than hormone replacement therapy with synthetic hormones. Synthetic forms of hormone replacement therapy prescribe substances such as Premarin, Provera and Prempro and present real health risks with increased risks of breast cancer, stroke and heart attack.

"Many physicians and so-called experts state that there is no evidence that bioidentical hormones are safer than synthetic HRT. A thorough review of the medical literature, however, clearly supports the claim that bioidentical hormones have some distinctly different, often opposite, physiological effects to those of their synthetic hormones," said Dr. Holtorf, whose practice treats more than 7,000 patients each year. "The medical literature demonstrates that bioidentical hormone replacement therapy is highly effective and carries a reduced, rather than an increased risk of breast cancer and cardiovascular disease."

The review also showed that patients undergoing bioidentical HRT were less likely to experience sleep problems, anxiety, depression and cognitive effects - common side effects of synthetic hormones and are associated with a reduced risk for breast cancer and superior cardiovascular protection.

"While larger, randomized clinical studies are needed, the review of current medical literature demonstrates that bioidentical hormones are a safer, highly effective option for women, and any physician that is practicing evidence-based medicine should be using bioidentical hormone replacement for their patients," said Dr. Holtorf.

Synthetic HRT preparations, which are the most commonly prescribed method of HRT in the United States, are comprised of pregnant horse hormones that are not found in the human body or synthetic hormones that have physiologic effects that mimic or mirror the natural estrogen or progesterone effects in the body. In contrast, bioidentical hormone replacement contains molecules that are exact replicas of the endogenous estrogens and progesterone found in the body and, as such, have distinctly different physiological effects than their synthetic counterparts.

The Holtorf Medical Group is one of the leading authorities on hormone replacement and has been educating patients on the superiority and safety of natural hormones versus synthetic for many years. Dr. Holtorf is available to discuss the FDA's move to halt the use of bioidentical hormones while promoting synthetic hormone therapy, and why discouraging healthcare professionals from using this treatment threatens the health of women everywhere. In addition, Dr. Holtorf can dispel the common misconceptions associated with bioidentical hormone treatment and discuss the significant health benefits patients can expect from this treatment compared to synthetic versions of HRT. For more information or for a copy of the study go to www.HoltorfMed.com.


'/>"/>
SOURCE The Holtorf Medical Group
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BioNanomatrix Announces Issuance of Key Nanofluidics Patent Enabling Single Molecule Whole Genome Analysis
2. SeqWright Unveils ABI SOLiD(TM) Next Generation Genetic Analysis System
3. Topline Findings from Comparative Analysis of INVEGA(TM) and Quetiapine in Schizophrenia to be Postered at the 20th Annual U.S. Psychiatric and Mental Health Congress
4. Massive reanalysis of genome data solves case of the lethal genes
5. ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients
6. Gene Codes Corporation Announces Version 4.8 of Sequencher Software for DNA Sequence Assembly & Analysis
7. Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone
8. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
9. Credit-card-sized platform for volatile compound analysis CAREER project goal
10. New Glycobiology Analysis Manual 2nd Edition Provides Valuable Resource for Novices and Experts in the Field
11. Pharsights Reporting and Analysis Services Business Unit to Leverage New Validated Data Management System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... Nov. 30, 2016  GenomOncology today announced the appointment of ... Medical Affairs.  Dr. Coleman will oversee clinical ... proprietary knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists ... data and clinical decision support, from quality control through reporting. ... , , ...
(Date:11/30/2016)... SEATTLE , Nov. 30, 2016  The ... Allen Cell Collection: the first publicly available collection ... stem cells that target key cellular structures with ... Medical Research, these powerful tools are a crucial ... cells to better understand what makes human cells ...
(Date:11/30/2016)... , 30. November 2016   ... hat heute die Unterzeichnung einer Reihe von ... zufolge wird Evotec AG Screeningleistungen für Mercks ... bereitstellen. Der Zugriff auf diese Bibliotheken in ... eröffnet einen schnelleren Weg zur Ermittlung und ...
(Date:11/30/2016)... ... November 30, 2016 , ... Energetiq Technology, ... introduces the 5th generation, ultra-bright, Laser-Driven Light Source, the EQ-77, at the MRS ... technology, the EQ-77 offers higher radiance and irradiance from a truly broadband white ...
Breaking Biology Technology:
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
Breaking Biology News(10 mins):